Halifax, Canada · Founded 2012 · Privately Held (backing)
Developer of a microsphere product designed to improve the treatment of hypervascular tumors. ABK Biomedical is based in Halifax, Canada and was founded in 2012. Its last reported valuation was $73 million in Dec 2022. It has raised $122 million across 4 recorded rounds; the latest was a $2.6 million seed round in Oct 2025.
Last reported valuation
$73.0M
Oct 2026
Priced at
—
Total raised
$121.7M
Last round
Seed Round
Oct 2025
No prints on record
No secondary trades in ABK Biomedical shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ABK Biomedical with a free account
·The complete investor list: 11 names
·Watch ABK Biomedical: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of ABK Biomedical stock.
